New Complaint Filed in N.D.Tex. Challenges Mifepristone Regulation
Document Type
Article
Publication Date
10-21-2024
Abstract
The States of Missouri, Kansas, and Idaho have sued the FDA challenging the regulatory framework for Mifepristone. The suit is filed in the United States District Court for the Northern District of Texas Amarillo Division.
Source Publication
Gender and Law Blog
Recommended Citation
Abrams, Jamie, "New Complaint Filed in N.D.Tex. Challenges Mifepristone Regulation" (2024). Popular Media. 593.
https://digitalcommons.wcl.american.edu/pub_disc_media/593
COinS